Javier Martín

发表

Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study

J. Blay, S. Ferrari, H. Gelderblom, 2012, Sarcoma.

Salvage surgical resection after high‐dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias—A study of the Spanish Group for Research on Sarcomas (GEIS)

C. Balañà, X. G. Del Muro, J. Maurel, 2004, Journal of surgical oncology.

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases

C. Antonescu, E. Wardelmann, R. Sciot, 2008, Modern Pathology.

Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

A. D. Dei Tos, P. Casali, R. Miceli, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of temozolomide as a 6‐week, continuous, oral schedule in patients with advanced soft tissue sarcoma

J. Maurel, A. Poveda, I. Bover, 2005, Cancer.

Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

X. Matías-Guiu, M. Santacana, A. Velasco, 2012, Virchows Archiv.

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

J. Maurel, A. de Juan, A. Poveda, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SEOM guidelines for gastrointestinal stromal sarcomas (GIST)

F. Rivera, A. Poveda, Javier Martín, 2012, Clinical and Translational Oncology.

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

A. Llombart‐Bosch, J. Maurel, J. López-Guerrero, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy

A. Llombart‐Bosch, A. D. Dei Tos, P. Casali, 2012, Cancer.

Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.

J. J. de la Cruz, C. Balañà, R. Andrés, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential dose‐dense doxorubicin and ifosfamide for advanced soft tissue sarcomas

C. Balañà, J. Maurel, A. Casado, 2004, Cancer.

Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy

A. D. Dei Tos, P. Casali, A. Gronchi, 2012, Cancer.

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

A. Antón, A. Poveda, A. Casado, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.